During the past decade, Odense Universitetshospital, Onkologisk Afdeling R conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Odense Universitetshospital, Onkologisk Afdeling R" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Odense Universitetshospital, Onkologisk Afdeling R" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Antimetabolites, Antineoplastic" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Odense Universitetshospital, Onkologisk Afdeling R" in a lesser frequency.

Most popular intervention types in "Odense Universitetshospital, Onkologisk Afdeling R" are "Drug" (24 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (7 trials), "Bevacizumab" (4 trials), "Paclitaxel" (4 trials), "Placebo" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Odense Universitetshospital, Onkologisk Afdeling R" are 21 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Odense Universitetshospital, Onkologisk Afdeling R". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Odense Universitetshospital, Onkologisk Afdeling R, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Odense Universitetshospital, Onkologisk Afdeling R, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".